Gentech Pharmaceutical’s Adderall Alternative Ad Banned by Harvard University

Share Article

The NY Daily News broke the story of Harvard University’s student newspaper pulling down the ad for ADDTabz – the Adderall Alternative. The story is not new for Gentech Pharmaceutical, based out of both the US and UK. ADDTabz might have rave reviews from the students of college campuses around the country, but that doesn’t mean it has the broad based support of the colleges themselves.

Gentech Pharmaceutical

Gentech Pharmaceutical

I believe the students should have the right to make up their own minds, as well as to know that there is an alternative pathway for them to take other than using dangerous drugs - especially if they don’t have a legal prescription.

Most universities around the US have been dealing with a much larger issue for many years – the actual abuse by their students of amphetamine type study drugs such as Adderall. Katie Couric reported with CBS News that according to a study at the University of Kentucky, 34% of undergrads surveyed said they had taken drugs like Adderall to improve cognitive abilities as a study aid.

The Harvard newspaper itself has run several stories in the past about Adderall use on Harvard’s campus, reports Christine Roberts (NY Daily News). So why pull an ad for a non-prescription/non-drug alternative to Adderall?

"That really is the six million dollar question.", replied Gentech CEO Derek Vest. “I believe the students should have the right to make up their own minds, as well as to know that there is an alternative pathway for them to take other than using dangerous drugs - especially if they don’t have a legal prescription.”

Gentech Pharmaceutical creates non-prescription pharmaceuticals that are designed as a safer and effective alternative to prescription drugs and medications. While it is true that ADDTabz is referred to as a “Smart Drug” or “Study Drug”, Gentech insists that it not classified or considered a drug by the FDA or DEA, but rather that ADDTabz falls into the category of Nutritional Supplements.

Adderall has been in the press a lot this past year for not only the college abuse scandals, but also because of the severe shortage and subsequent inability for many legitimate prescription holders to find a pharmacy that have the drug in stock. The problem was bad enough that President Barack Obama signed an executive order in October of last year ordering drug shortage relief.

“Gentech Pharmaceutical is really the good guy in this case.”, says CEO Derek Vest. “We are trying to help students move away from dangerous drugs while providing them with a superior product to help them achieve all their academic aspirations”.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Tiffany Davis
Follow us on
Visit website